GoKawiil
Tech News
Novo Nordisk this week detailed plans to diversify its business beyond its blockbuster obesity and diabetes treatments, according to CNBC reporting. The move comes as the Danish drugmaker faces intensifying competition from Eli Lilly in the weight-loss drug market.
Anthropic has confirmed to TechCrunch that it operates a physical biology lab in the Bay Area, where its AI models help design and test experiments in real life. The company says the lab focuses on fundamental biology research rather than drug discovery, and works both internally and with outside partners, building on its April acquisition of stealth biotech startup Coefficient Bio.
Novo Nordisk, the Danish pharmaceutical company known for Ozempic and Wegovy, is rebranding itself as simply 'Novo' starting this week. The move shifts the company's public identity toward a shorter, more casual name as it markets directly to consumers rather than solely to healthcare providers.